Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2014-08-13 Earnings Release
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Earnings Release 2014
Earnings Release Classification · 100% confidence The document provides unaudited performance figures for Q2 and H1, including revenue, EBITDA, and cash flow comparisons to the previous year. It also updates the 2014 financial guidance and mentions that the company will host a conference call to review these results. This structure—key financial highlights for a period followed by guidance updates—is characteristic of an Earnings Release (ER). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), as it focuses on highlights and guidance rather than detailed statements. The mention of the conference call confirms the immediate release of results. H1 2014
2014-08-13 English
Earnings Release 2014
Earnings Release Classification · 98% confidence The document provides key financial highlights for a specific period (Q2 and H1), including revenue, EBITDA, and cash flow figures, along with updated financial guidance for the full year 2014. This structure strongly indicates an initial announcement of periodic financial results, which aligns with the Earnings Release (ER) definition. Although it mentions a conference call where management will review results, the core content is the summary of performance, not the full transcript (CT) or a comprehensive interim report (IR). Given the focus on key performance indicators and guidance update, ER is the most appropriate classification. H1 2014
2014-08-13 English
Report Publication Announcement 2014
Report Publication Announcement Classification · 99% confidence The document explicitly states that ALK will 'release its interim report for the six months ended 30 June 2014' on a future date (August 13, 2014). It then provides details for a conference call and mentions that the 'related presentation will be available shortly before the conference call begins.' Since the document is an announcement about the future release of an interim report and associated materials (conference call/presentation), and it is very short (1116 chars), it fits the definition of a Report Publication Announcement (RPA) rather than the Interim Report (IR) itself.
2014-08-06 English
Report Publication Announcement 2014
Report Publication Announcement Classification · 98% confidence The document is a short company release (2630 characters) dated August 6, 2014. The primary content announces the upcoming release date (August 13, 2014) of the 'interim report for the six months ended 30 June 2014' (Q2 2014). It also details logistics for a related conference call and mentions where the presentation will be available. According to Rule #2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of a report, rather than being the report itself, should be classified as a Report Publication Announcement (RPA). This is not the comprehensive Interim Report (IR) itself, but the announcement of its release.
2014-08-06 English
Board/Management Information 2014
Board/Management Information Classification · 99% confidence The document is titled "Selskabsmeddelelse nr. 25/2014" (Company Announcement no. 25/2014) and its primary content is the announcement of a new Executive Vice President (Helle Skov) joining the management team and taking responsibility for Product Supply. This directly corresponds to the definition of Board/Management Information, which covers announcements of changes in senior management. The filing code for this is MANG.
2014-07-01 English
Regulatory Filings 2014
Regulatory Filings
2014-07-01 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.